Vinson & Elkins advised Lexicon Pharmaceuticals, Inc. on the deal.Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) (“Lexicon”) announced it entered into a securities purchase agreement for a private investment…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
